Literature DB >> 11229851

Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution.

S C Johnson1, C A Benson, D W Johnson, A Weinberg.   

Abstract

We describe a 42-year-old man with human immunodeficiency virus infection who developed multiple recurrences of cytomegalovirus (CMV) retinitis despite receiving highly active antiretroviral therapy and having apparent immune reconstitution as evidenced by CD4(+) T lymphocyte counts of > 200 cells/mm(3). Laboratory investigation during one recurrence of retinitis confirmed that there was active CMV replication in the plasma and vitreous fluid. In addition, lymphoproliferative responses to CMV antigens were absent despite evidence of reactivity to Candida antigen and pokeweed mitogen. The clinical significance of this case and of other recently reported cases is discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11229851     DOI: 10.1086/319219

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  15 in total

1.  Molluscum contagiosum in an immune reconstituted AIDS patient.

Authors:  T Albini; N Rao
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

2.  Recurrent CMV retinitis in non HIV.

Authors:  Viroj Wiwanitkit
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-18       Impact factor: 3.117

3.  Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture.

Authors:  Douglas A Jabs
Journal:  Am J Ophthalmol       Date:  2010-12-18       Impact factor: 5.258

Review 4.  Immune restoration diseases reflect diverse immunopathological mechanisms.

Authors:  Patricia Price; David M Murdoch; Upasna Agarwal; Sharon R Lewin; Julian H Elliott; Martyn A French
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

5.  Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes.

Authors:  Douglas A Jabs; Alka Ahuja; Mark Van Natta; Alice Lyon; Sunil Srivastava; Sapna Gangaputra
Journal:  Ophthalmology       Date:  2010-07-29       Impact factor: 12.079

6.  Comparative analysis of human cytomegalovirus-specific CD4(+) T-cell frequency and lymphoproliferative response in human immunodeficiency virus-positive patients.

Authors:  G Piccinini; G Comolli; E Genini; D Lilleri; R Gulminetti; R Maccario; M G Revello; G Gerna
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

7.  Cytomegalovirus Retinitis in Patients With Acquired Immunodeficiency Syndrome After Initiating Antiretroviral Therapy.

Authors:  Douglas A Jabs; Mark L Van Natta; Gary N Holland; Ronald Danis
Journal:  Am J Ophthalmol       Date:  2016-10-27       Impact factor: 5.258

8.  Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis.

Authors:  Janet T Holbrook; Ryan Colvin; Mark L van Natta; Jennifer E Thorne; Mark Bardsley; Douglas A Jabs
Journal:  Am J Ophthalmol       Date:  2011-07-13       Impact factor: 5.258

9.  Effect of host genetics on the development of cytomegalovirus retinitis in patients with AIDS.

Authors:  Efe Sezgin; Douglas A Jabs; Sher L Hendrickson; Mark Van Natta; Alexander Zdanov; Richard Alan Lewis; Michael W Smith; Jennifer L Troyer; Stephen J O'Brien
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

10.  Canadian consensus guidelines for the management of cytomegalovirus disease in HIV/AIDS.

Authors:  Richard G Lalonde; Guy Boivin; Jean Deschênes; William G Hodge; J Jill Hopkins; Alex H Klein; Janette I Lindley; Peter Phillips; Stephen D Shafran; Sharon Walmsley
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-11       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.